Funding & Reimbursement Latest News

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video introducing the Pricing Audit…

From July 2025, Category A reimbursement prices will be based on data from suppliers obtained under the Health Service Products (Provision and Disclosure of Information)…

In response to a significant ongoing disruption to the supply of Venlafaxine 37.5mg modified-release tablets, a Serious Shortage Protocol (SSP) has been issued by the…

Following on from last week’s Spending Review announcement, Community Pharmacy England has joined forces with other national primary care bodies to reiterate our call on…

The Government’s Spending Review has concluded, with Chancellor Rachel Reeves today announcing the Government’s new spending priorities. The announcement included a 3% real terms uplift…

Update 27/11/25: From 1 December 2025, the use of the ‘FS’ prescriber endorsement has been extended to treatments used in the management of tuberculosis (TB)…